Evidence map›Paper›PMID 30572869›Full record

Observational studyBMC pulmonary medicine2018

Guideline adherence in hospital recruited and population based COPD patients.

Bahareh Jouleh, Marta Erdal, Tomas Mikal Eagan, Per Bakke, Amund Gulsvik, Rune Nielsen

Open access · goldAbstract readComparative StudyObservational Study
In one paragraph

Observational study in BMC pulmonary medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Impact of an Inpatient COPD Care Pathway on Hospital Care Process and Outcome Metrics.Chronic obstructive pulmonary diseases (Miami, Fla.) · 2025
    Article
  2. Article
  3. Article
  4. Review
  5. Does Evaluation and Management of COPD Follow Therapeutic Strategy Recommendations?Chronic obstructive pulmonary diseases (Miami, Fla.) · 2021
    Article
  6. Cognitive Behavioral Therapy for People with Chronic Obstructive Pulmonary Disease: Rapid Review.International journal of chronic obstructive pulmonary disease · 2020
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Bahareh JoulehDepartment of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway.
Marta ErdalDepartment of Clinical Science, University of Bergen, N-5021, Bergen, Norway. marta.erdal@uib.no.
Tomas Mikal EaganDepartment of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway.
Per BakkeDepartment of Clinical Science, University of Bergen, N-5021, Bergen, Norway.
Amund GulsvikDepartment of Clinical Science, University of Bergen, N-5021, Bergen, Norway.
Rune NielsenDepartment of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway.
University of Bergen · NOHaukeland University Hospital · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEvidence from several studies show poor guideline adherence to COPD treatment, but no such study has been undertaken in Norway. The objectives of this study, was to estimate and compare the guideline adherence to COPD treatment in general population-based and hospital-recruited COPD patients, and find possible predictors of guideline adherence.

methodsFrom the prospective, observational EconCOPD-study, we analysed guideline adherence for 90 population-based COPD cases compared to 245 hospital-recruited COPD patients. Overall guideline adherence was defined as correct pharmacological treatment, and influenza vaccination the preceding year, and having received smoking cessation advice. Multivariate logistic regression analysis was performed with the dichotomous outcome overall guideline adherence adjusting for relevant variables.

resultsThe overall guideline adherence for population-based COPD cases was 6.7%, significantly lower than the 29.8% overall guideline-adherence amongst hospital-recruited COPD patients. Adherence to pharmacological treatment guidelines was 10.0 and 35.5%, for the two recruitment sources, respectively. GOLD-stage 3 to 4 was associated with significantly better guideline adherence compared to GOLD-stage 2 (OR (95% CI) 18.9 (8.37,42.7)). The unadjusted difference between the two recruitment sources was completely explained by degree of airflow obstruction.

conclusionOverall guideline adherence was very low for both recruitment sources. We call for increased attention from authorities and healthcare personnel to improve the quality of care given to this patient group.

Indexed as

Quality of Health CareAgedDirective CounselingFemaleGuideline AdherenceHospitalsHumansInfluenza, HumanInfluenza VaccinesMaleMiddle AgedPatient SelectionProspective StudiesPulmonary Disease, Chronic ObstructiveSeverity of Illness IndexSmoking CessationInfluenza VaccinesAdherenceChronic obstructive pulmonary diseaseGeneral populationGuidelines

Identifiers

PMID30572869
PMCPMC6302492
OpenAlexW2905037792

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.